AU6763290A – Benzofuran derivatives
– Google Patents
AU6763290A – Benzofuran derivatives
– Google Patents
Benzofuran derivatives
Info
Publication number
AU6763290A
AU6763290A
AU67632/90A
AU6763290A
AU6763290A
AU 6763290 A
AU6763290 A
AU 6763290A
AU 67632/90 A
AU67632/90 A
AU 67632/90A
AU 6763290 A
AU6763290 A
AU 6763290A
AU 6763290 A
AU6763290 A
AU 6763290A
Authority
AU
Australia
Prior art keywords
benzofuran derivatives
benzofuran
derivatives
Prior art date
1989-12-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU67632/90A
Other versions
AU638077B2
(en
Inventor
Kevin Stuart Cardwell
Michael Dennis Dowle
Torquil Iain Maclean Jack
David Middlemiss
Barry Clive Ross
David Ian Carter Scopes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1989-12-01
Filing date
1990-11-30
Publication date
1991-06-06
1989-12-22
Priority claimed from GB898929071A
external-priority
patent/GB8929071D0/en
1990-05-18
Priority claimed from GB909011186A
external-priority
patent/GB9011186D0/en
1990-09-06
Priority claimed from GB909019436A
external-priority
patent/GB9019436D0/en
1990-11-30
Application filed by Glaxo Group Ltd
filed
Critical
Glaxo Group Ltd
1991-06-06
Publication of AU6763290A
publication
Critical
patent/AU6763290A/en
1993-06-17
Application granted
granted
Critical
1993-06-17
Publication of AU638077B2
publication
Critical
patent/AU638077B2/en
2010-11-30
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P13/00—Drugs for disorders of the urinary system
A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P15/00—Drugs for genital or sexual disorders; Contraceptives
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer’s disease or other forms of dementia
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P27/00—Drugs for disorders of the senses
A61P27/02—Ophthalmic agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/08—Vasodilators for multiple indications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/12—Antihypertensives
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
C07C45/54—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C47/00—Compounds having —CHO groups
C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
C07C47/56—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups
C07C47/565—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups all hydroxy groups bound to the ring
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
C07C49/825—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups all hydroxy groups bound to the ring
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
AU67632/90A
1989-12-01
1990-11-30
Benzofuran derivatives
Ceased
AU638077B2
(en)
Applications Claiming Priority (9)
Application Number
Priority Date
Filing Date
Title
GB8927277
1989-12-01
GB898927277A
GB8927277D0
(en)
1989-12-01
1989-12-01
Chemical compounds
GB898929071A
GB8929071D0
(en)
1989-12-22
1989-12-22
Chemical compounds
GB8929071
1989-12-22
GB909011186A
GB9011186D0
(en)
1990-05-18
1990-05-18
Chemical compounds
GB9011186
1990-05-18
GB909019436A
GB9019436D0
(en)
1990-09-06
1990-09-06
Chemical compounds
GB9019436
1990-09-06
OA60008A
OA10044A
(en)
1989-12-01
1991-05-28
Benzofuran derivatives
Publications (2)
Publication Number
Publication Date
AU6763290A
true
AU6763290A
(en)
1991-06-06
AU638077B2
AU638077B2
(en)
1993-06-17
Family
ID=33314473
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU67632/90A
Ceased
AU638077B2
(en)
1989-12-01
1990-11-30
Benzofuran derivatives
Country Status (16)
Country
Link
EP
(1)
EP0434249A3
(en)
JP
(1)
JPH04217975A
(en)
CN
(1)
CN1052672A
(en)
AU
(1)
AU638077B2
(en)
CA
(1)
CA2031324A1
(en)
CZ
(1)
CZ597190A3
(en)
FI
(1)
FI905908A
(en)
GB
(1)
GB8927277D0
(en)
HU
(1)
HUT61751A
(en)
IE
(1)
IE904333A1
(en)
IL
(1)
IL96516A0
(en)
NO
(1)
NO905201L
(en)
NZ
(1)
NZ236297A
(en)
OA
(1)
OA10044A
(en)
PL
(1)
PL288039A1
(en)
PT
(1)
PT96042A
(en)
Cited By (3)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU628121B2
(en)
*
1989-01-05
1992-09-10
Du Pont Pharmaceuticals Company
Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors
AU654350B2
(en)
*
1991-05-16
1994-11-03
Glaxo Group Limited
Benzofuran derivatives
AU654349B2
(en)
*
1991-05-16
1994-11-03
Glaxo Group Limited
Benzofuran derivatives
Families Citing this family (42)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US5183810A
(en)
*
1990-02-13
1993-02-02
Merck & Co., Inc.
Imidazole angiotensin II antagonists incorporating a substituted benzyl element
US5177095A
(en)
*
1990-02-13
1993-01-05
Merck & Co., Inc.
Triazole angiotensin II antagonists incorporating a substituted benzyl element
US5240938A
(en)
*
1991-02-13
1993-08-31
Merck & Co., Inc.
Angiotensin II antagonists incorporating a substituted pyridoimidazolyl ring
US5449682A
(en)
*
1990-02-13
1995-09-12
Merck & Co., Inc.
Angiotensin II antagonists incorporating a substituted benzyl element
EP0443983B1
(en)
*
1990-02-19
1996-02-28
Ciba-Geigy Ag
Acyl compounds
GB9026006D0
(en)
*
1990-11-29
1991-01-16
Glaxo Group Ltd
Chemical compounds
IL100917A0
(en)
*
1991-02-16
1992-11-15
Fisons Plc
Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
AU1417092A
(en)
*
1991-03-25
1992-10-21
Glaxo Group Limited
1-imidazolgemethyl benzofuran derivatives as inhibitors of angiotensin ii activity
US5177074A
(en)
*
1991-03-26
1993-01-05
Merck & Co., Inc.
Angiotensin ii antagonists incorporating a substituted thiophene or furan
US5252574A
(en)
*
1991-04-26
1993-10-12
Merck & Co., Inc.
Angiotensin II antagonists incorporating a substituted thiophene or furan
US5198438A
(en)
*
1991-05-07
1993-03-30
Merck & Co., Inc.
Angiotensin ii antagonists incorporating a substituted thiophene or furan
GB9110635D0
(en)
*
1991-05-16
1991-07-03
Glaxo Group Ltd
Chemical compounds
GB9110623D0
(en)
*
1991-05-16
1991-07-03
Glaxo Group Ltd
Chemical compounds
EP0514192A1
(en)
*
1991-05-16
1992-11-19
Glaxo Group Limited
Antihypertensive benzofuran derivatives, substituted by varied N-pyrimidinyl- or N-imidazolyl-methyl groups
GB9110625D0
(en)
*
1991-05-16
1991-07-03
Glaxo Group Ltd
Chemical compounds
GB9113626D0
(en)
*
1991-06-25
1991-08-14
Ici Plc
Heterocyclic compounds
GB9113628D0
(en)
*
1991-06-25
1991-08-14
Ici Plc
Heterocyclic derivatives
ATE152718T1
(en)
*
1991-08-15
1997-05-15
Ciba Geigy Ag
N-ACYL-N-HETEROCYCLYL OR NAPHTHYLALKYL AMINO ACIDS AS ANGIOTENSIN II ANTAGONISTS
TW300219B
(en)
*
1991-09-14
1997-03-11
Hoechst Ag
US5187159A
(en)
*
1991-10-07
1993-02-16
Merck & Co., Inc.
Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole
DE4140519A1
(en)
*
1991-12-09
1993-06-17
Merck Patent Gmbh
benzofurans
US5225408A
(en)
*
1991-12-20
1993-07-06
E. R. Squibb & Sons, Inc.
Biphenyl oxadiazinone angiotensin II inhibitors
US5364869A
(en)
*
1992-03-09
1994-11-15
Abbott Laboratories
Heterocycle-substituted benzyaminopyridine angiotensin II receptor antagonists
US5972990A
(en)
*
1992-04-10
1999-10-26
Brigham And Women’s Hospital, Inc.
Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
DE69325574T2
(en)
*
1992-04-13
2000-03-16
Zeneca Ltd
ANGIOTENSIN II ANTAGONISTS AGAINST DISEASES; THE WITH A RESTRICTED; NEURONAL LINE SPEED ARE CONNECTED, ESPECIALLY DIABETIC NEUROPATHY
US5294722A
(en)
*
1992-04-16
1994-03-15
E. R. Squibb & Sons, Inc.
Process for the preparation of imidazoles useful in angiotensin II antagonism
EP0577025A3
(en)
*
1992-07-01
1998-02-04
Hoechst Aktiengesellschaft
Angiotensin-ii-receptorantagonist for the treatment and prophylaxis of coronary heart diseases
US5310929A
(en)
*
1992-08-06
1994-05-10
E. I. Du Pont De Nemours And Company
Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
GB9217723D0
(en)
*
1992-08-20
1992-09-30
Ici Plc
Chemical process
GB9223860D0
(en)
*
1992-11-13
1993-01-06
Glaxo Group Ltd
Chemical compounds
US5284841A
(en)
*
1993-02-04
1994-02-08
Merck & Co., Inc.
Benzo-fused lactams promote release of growth hormone
GB2279346A
(en)
*
1993-07-01
1995-01-04
Glaxo Group Ltd
Benzofuran intermediates
SE9903028D0
(en)
1999-08-27
1999-08-27
Astra Ab
New use
DE10154313A1
(en)
2001-11-05
2003-05-15
Bayer Cropscience Ag
Halogen-nitro-butadiene
US8034782B2
(en)
2008-07-16
2011-10-11
Synergy Pharmaceuticals, Inc.
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2
(en)
2007-06-04
2015-03-03
Synergy Pharmaceuticals, Inc.
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2170930B3
(en)
2007-06-04
2013-10-02
Synergy Pharmaceuticals Inc.
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2627848T3
(en)
2008-06-04
2017-07-31
Synergy Pharmaceuticals Inc.
Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2
(en)
2010-09-15
2017-04-11
Synergy Pharmaceuticals, Inc.
Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1
(en)
2013-03-15
2014-09-25
Synergy Pharmaceuticals Inc.
Compositions useful for the treatment of gastrointestinal disorders
CA2905438A1
(en)
2013-03-15
2014-09-25
Synergy Pharmaceuticals Inc.
Agonists of guanylate cyclase and their uses
CA2913737A1
(en)
2013-06-05
2014-12-11
Synergy Pharmaceuticals, Inc.
Ultra-pure agonists of guanylate cyclase c, method of making and using same
Family Cites Families (4)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
GB2118552A
(en)
*
1982-04-15
1983-11-02
Pfizer Ltd
Thromboxane synthetase inhibitors
US4452986A
(en)
*
1982-06-08
1984-06-05
The Upjohn Company
Imidazolyl-substituted benzofurans
EP0291172B1
(en)
*
1987-04-14
1992-11-19
Glaxo Group Limited
Ketone derivatives
EP0445073A1
(en)
*
1990-02-27
1991-09-04
Ciba-Geigy Ag
Benzofurans
1989
1989-12-01
GB
GB898927277A
patent/GB8927277D0/en
active
Pending
1990
1990-11-30
CZ
CS905971A
patent/CZ597190A3/en
unknown
1990-11-30
NZ
NZ236297A
patent/NZ236297A/en
unknown
1990-11-30
PL
PL28803990A
patent/PL288039A1/en
unknown
1990-11-30
PT
PT96042A
patent/PT96042A/en
unknown
1990-11-30
IL
IL96516A
patent/IL96516A0/en
unknown
1990-11-30
EP
EP19900313051
patent/EP0434249A3/en
not_active
Withdrawn
1990-11-30
IE
IE433390A
patent/IE904333A1/en
unknown
1990-11-30
FI
FI905908A
patent/FI905908A/en
not_active
IP Right Cessation
1990-11-30
CN
CN90110419A
patent/CN1052672A/en
active
Pending
1990-11-30
NO
NO90905201A
patent/NO905201L/en
unknown
1990-11-30
AU
AU67632/90A
patent/AU638077B2/en
not_active
Ceased
1990-11-30
HU
HU908016A
patent/HUT61751A/en
unknown
1990-12-01
JP
JP2403409A
patent/JPH04217975A/en
active
Pending
1990-12-03
CA
CA002031324A
patent/CA2031324A1/en
not_active
Abandoned
1991
1991-05-28
OA
OA60008A
patent/OA10044A/en
unknown
Cited By (3)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU628121B2
(en)
*
1989-01-05
1992-09-10
Du Pont Pharmaceuticals Company
Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors
AU654350B2
(en)
*
1991-05-16
1994-11-03
Glaxo Group Limited
Benzofuran derivatives
AU654349B2
(en)
*
1991-05-16
1994-11-03
Glaxo Group Limited
Benzofuran derivatives
Also Published As
Publication number
Publication date
NZ236297A
(en)
1992-10-28
EP0434249A2
(en)
1991-06-26
OA10044A
(en)
1996-10-14
PT96042A
(en)
1991-09-13
AU638077B2
(en)
1993-06-17
CN1052672A
(en)
1991-07-03
JPH04217975A
(en)
1992-08-07
NO905201D0
(en)
1990-11-30
GB8927277D0
(en)
1990-01-31
HU908016D0
(en)
1991-06-28
CZ597190A3
(en)
1995-02-15
EP0434249A3
(en)
1992-02-12
FI905908A0
(en)
1990-11-30
NO905201L
(en)
1991-06-03
IE904333A1
(en)
1991-06-05
FI905908A
(en)
1991-06-02
HUT61751A
(en)
1993-03-01
CA2031324A1
(en)
1991-06-02
PL288039A1
(en)
1991-08-12
IL96516A0
(en)
1991-08-16
Similar Documents
Publication
Publication Date
Title
AU6763290A
(en)
1991-06-06
Benzofuran derivatives
AU4764990A
(en)
1990-07-19
3-Aryl-4-hydroxy-delta3-pyrroline-2-one derivatives
AU636155B2
(en)
1993-04-22
Thienodiazepine derivatives
AU623795B2
(en)
1992-05-21
New substituted 1h-indazole-3-carboxamides
AU6799990A
(en)
1991-06-20
2-iminopyridine derivatives
AU1855688A
(en)
1989-01-12
Benzopyran derivatives
AU1632192A
(en)
1993-03-11
Benzofuran derivatives
AU3390189A
(en)
1989-11-09
Chroman derivatives
AU631896B2
(en)
1992-12-10
3-arylurail derivatives
AU629989B2
(en)
1992-10-15
Phenethanolamine derivatives
AU6670090A
(en)
1991-07-11
Substituted pyrimidobenzimidazole derivatives
AU1632092A
(en)
1993-03-11
Benzofuran derivatives
AU623797B2
(en)
1992-05-21
Chroman derivatives
AU3644089A
(en)
1989-12-21
Chroman derivatives
AU623544B2
(en)
1992-05-14
Chroman derivatives
AU6204690A
(en)
1991-03-07
Epiopodophyllotoxin altroside derivatives
AU4256589A
(en)
1990-04-26
Chroman derivatives
AU2963389A
(en)
1989-08-03
Pyranobenzoxadiazole derivatives
AU5911190A
(en)
1991-01-24
4-phenylpyridonyl chroman derivatives
EP0435322A3
(en)
1992-03-18
Benzofuran derivatives
AU632104B2
(en)
1992-12-17
Substituted pyrimidin-6-ones(-6-thiones)
AU4601389A
(en)
1990-06-14
Novel benzopyranylpyrrolinone derivatives
AU5514090A
(en)
1990-11-22
Milbemycin derivatives
AU5400390A
(en)
1990-11-05
Substituted 1-phenylnaphthalenes
AU5938390A
(en)
1991-01-17
Bis-acyloxymethyl derivatives
None